79296324 - ORPHALAN INNOVATION FOR ORPHAN DISEASES

Information

  • Trademark
  • 79296324
  • Serial Number
    79296324
  • Registration Number
    6599549
  • Filing Date
    September 09, 2020
    4 years ago
  • Registration Date
    December 28, 2021
    2 years ago
  • Transaction Date
    July 05, 2022
    2 years ago
  • Status Date
    December 28, 2021
    2 years ago
  • Published for Opposition Date
    October 12, 2021
    3 years ago
  • Location Date
    December 28, 2021
    2 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    BETTS, MARCYA N
  • Attorney Docket Number
    008219.00123
    Attorney Name
    Heather R. Smith-Carra
    Law Office Assigned Location Code
    L60
  • Owners
Mark Drawing Code
3000
Mark Identification
ORPHALAN INNOVATION FOR ORPHAN DISEASES
Case File Statements
  • DM0000: The mark consists of a navy blue drop and light purple drop facing each other at its points. To the top left of the drops is a sky blue square with its upper left vertex rounded. To the bottom right of the drops is a purple circle. To the right of the aforementioned elements is the stylized navy blue wording "ORPHALAN" followed by a grey vertical band with the stylized stacked sky blue wording "INNOVATION FOR ORPHAN DISEASES" following the vertical band.
  • GS0051: diagnostic agents for pharmaceutical use; capsules sold empty for pharmaceutical use; pharmaceutical compounds for the treatment of orphan diseases; pharmaceutical products for the treatment of orphan diseases; chemical preparations for pharmaceutical use, namely, for the treatment of orphan diseases; chemical preparations for medical use, for the treatment of orphan diseases; medicines for the development of treatment for orphan diseases
  • CC0000: The colors navy blue, sky blue, purple, light purple and gray are claimed as a feature of the mark.
  • GS0441: Advice relating to pharmacy, namely, advice relating to the use of pharmaceuticals for the treatment of orphan diseases; advisory services relating to health; pharmaceutical advice; advice relating to medicines; information to patients on administering medicines; medical information; drug use testing service for medical use; pharmaceutical services, namely, pharmaceutical compounding services and information services relating to diagnostic, prophylactic and therapeutic properties of pharmaceutical products; medical testing and analysis services for diagnostic or treatment of orphan disease; health advisory services relating to the use and operation of medical apparatus and instruments for treatment of orphan disease; medical diagnosis of orphan diseases
  • GS0101: Medical apparatus and instruments for diagnosing and treating orphan diseases; surgical apparatus and instruments; diagnostic apparatus for medical use for diagnosing orphan diseases; immunochemical testing apparatus for medical use; medical testing instruments for diagnosing and treating orphan diseases; substance analysis apparatus, namely, medical devices and medical instruments for the analysis of body fluids; instruments for extraction of liquids from the human body, namely, medical devices for obtaining body fluid samples; blood testing apparatus; radiology apparatus for medical use; blood testing instruments, namely, needles for medical use and veterinary use; resuscitation apparatus; gloves for medical use; gloves for veterinary use; syringes for medical use; fluid injectors for medical use; X-rays for medical use; inhalers for medical use; radiology screens for medical use; containers for applying medicines being medical tubing for administering drugs; special containers for medical waste; probes for medical use; thermometers for medical use; medical cases, namely, cases fitted for medical instruments; stethoscopes; heart pacemakers; electromagnetic diagnostic imaging apparatus for medical use; needles for medical use
  • D10000: "INNOVATION FOR ORPHAN DISEASES"
  • GS0421: Development of pharmaceutical preparations and medicines; development of pharmaceutical products; providing information on clinical studies for pharmaceutical products via an interactive website; evaluation of pharmaceutical products; scientific research in the field of pharmacy; research regarding pharmaceutical products; pharmaceutical research and development; research relating to pharmaceutical products; research and development for the pharmaceutical industry; conducting clinical trials for other in the field of pharmaceutical products; pharmaceutical drug development services; laboratory research services relating to pharmaceutical products; pharmaceutical research services; medical and pharmacological research services; pharmaceutical research and development services; Scientific research for medical purposes; scientific laboratory services; research and development in the field of biotechnology; design and development of medical diagnostic apparatus
Case File Event Statements
  • 7/5/2022 - 2 years ago
    32 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO
  • 6/9/2022 - 2 years ago
    31 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 6/9/2022 - 2 years ago
    30 - FINAL DISPOSITION PROCESSED Type: FIMP
  • 3/28/2022 - 2 years ago
    29 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 12/28/2021 - 2 years ago
    28 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 10/12/2021 - 3 years ago
    27 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 10/12/2021 - 3 years ago
    26 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 9/22/2021 - 3 years ago
    25 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 9/7/2021 - 3 years ago
    24 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 9/3/2021 - 3 years ago
    23 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 9/3/2021 - 3 years ago
    22 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 9/3/2021 - 3 years ago
    21 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 9/3/2021 - 3 years ago
    20 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 8/4/2021 - 3 years ago
    19 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 8/4/2021 - 3 years ago
    18 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 8/4/2021 - 3 years ago
    17 - TEAS REQUEST FOR RECONSIDERATION RECEIVED Type: ERFR
  • 4/22/2021 - 3 years ago
    16 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN
  • 4/22/2021 - 3 years ago
    15 - FINAL REFUSAL E-MAILED Type: GNFR
  • 4/22/2021 - 3 years ago
    14 - FINAL REFUSAL WRITTEN Type: CNFR
  • 4/10/2021 - 3 years ago
    13 - CHANGE OF NAME/ADDRESS REC'D FROM IB Type: ADCH
  • 3/27/2021 - 3 years ago
    12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 3/26/2021 - 3 years ago
    11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 3/26/2021 - 3 years ago
    10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 3/1/2021 - 3 years ago
    9 - REFUSAL PROCESSED BY IB Type: RFNT
  • 2/8/2021 - 3 years ago
    8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 2/8/2021 - 3 years ago
    7 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 1/28/2021 - 3 years ago
    6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 1/27/2021 - 3 years ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 1/19/2021 - 3 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 10/30/2020 - 4 years ago
    3 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 10/26/2020 - 4 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 10/22/2020 - 4 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR